CYCLO3PSS CORP
10QSB, EX-27, 2000-07-17
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: CYCLO3PSS CORP, 10QSB, 2000-07-17
Next: MAGNA LAB INC, 10QSB, 2000-07-17



<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTS FROM
     CYCLO3PSS CORPORATION'S FINANCIAL STATEMENTS AND IS QUALIRIFED IN ITS
     ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER>                                   1
<CURRENCY>                                     42,111

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                              FEB-28-2000
<PERIOD-START>                                 MAR-1-2000
<PERIOD-END>                                   MAY-31-2000
<EXCHANGE-RATE>                                1
<CASH>                                         42,111
<SECURITIES>                                   0
<RECEIVABLES>                                  130,996
<ALLOWANCES>                                   0
<INVENTORY>                                    17,930
<CURRENT-ASSETS>                               221,164
<PP&E>                                         30,127
<DEPRECIATION>                                 68,049
<TOTAL-ASSETS>                                 454,871
<CURRENT-LIABILITIES>                          944,093
<BONDS>                                        0
                          364
                                    364
<COMMON>                                       27,313
<OTHER-SE>                                     (516,900)
<TOTAL-LIABILITY-AND-EQUITY>                   454,871
<SALES>                                        180,757
<TOTAL-REVENUES>                               180,757
<CGS>                                          89,292
<TOTAL-COSTS>                                  456,130
<OTHER-EXPENSES>                               0
<LOSS-PROVISION>                               (274,969)
<INTEREST-EXPENSE>                             (87)
<INCOME-PRETAX>                                (274,969)
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            (274,969)
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (274,969)
<EPS-BASIC>                                  (.01)
<EPS-DILUTED>                                  (.01)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission